Tripeptide growth hormone secretagogues

Area of Science:

• Medicinal Chemistry
• Endocrinology

Background:

• Growth hormone (GH) secretagogues are crucial for stimulating GH release.
• Existing GH secretagogues, like hexarelin, are often larger peptides.
• Developing smaller, potent GH secretagogues is an ongoing research goal.

Purpose of the Study:

• To synthesize and evaluate C-terminus capped dipeptides and tripeptides as novel GH secretagogues.
• To determine if smaller peptide fragments can retain the activity of larger GH-releasing peptides.

Main Methods:

• Chemical synthesis of a series of C-terminus capped dipeptides and tripeptides.
• In vitro testing of synthesized peptides using a rat pituitary assay to measure GH secretagogue activity.

Main Results:

• Several synthesized tripeptides exhibited GH secretagogue activity.
• The tripeptide Aib-D-Trp-D-homoPhe-OEt displayed potent low nanomolar activity in the rat pituitary assay.
• This indicates that the activity of larger GH-releasing peptides can be replicated by smaller tripeptide structures.

Conclusions:

• C-terminus capped tripeptides can effectively mimic the GH secretagogue activity of larger peptides.
• The identified tripeptide represents a promising lead compound for further development.
• This study simplifies the structure of GH secretagogues while maintaining efficacy.